芳香化酶抑制对男性和绝经后女性GH分泌的中枢调节效应不同
开放标签交叉研究比较来曲唑和他莫昔芬对8名男性和14名绝经后女性GH分泌的影响。男性中来曲唑显著降低精氨酸刺激的GH峰值反应(Δ-49.4%±18.1%,P<0.05),他莫昔芬降低但未达统计学显著。绝经后女性中来曲唑不影响GH峰值,他莫昔芬显著降低GH峰值(Δ-47.3%±10%,P<0.05)。结论认为雌激素调节男性GH分泌,而绝经后女性因预先存在的雌激素缺乏,芳香化酶抑制呈中性效应。
要点
- 男性中来曲唑显著降低精氨酸刺激的GH峰值反应(P<0.05)。
- 绝经后女性中来曲唑不影响GH峰值,他莫昔芬显著降低GH峰值(P<0.05)。
- 男性来曲唑降低雌二醇(43.1±2.8降至12.7±1.3 pmol/L,P<0.001),女性基线及治疗中雌二醇均<11 pmol/L。
核心结论
- 雌激素剥夺降低循环GH,表明雌激素调节男性GH分泌。
- 绝经后女性中芳香化酶抑制呈中性效应,可能因预先存在的雌激素缺乏。
- 他莫昔芬在绝经后女性中抑制GH分泌,提示非雌激素受体介导机制。
- 与男性不同,雌激素在绝经后女性中不太可能介导GH分泌。
研究设计与样本
- 开放标签交叉研究,比较来曲唑(芳香化酶抑制剂)和他莫昔芬的效果。
- 8名男性和14名女性各接受他莫昔芬(20 mg/d)和来曲唑(2.5 mg/d)治疗2周。
- 主要终点为精氨酸刺激的GH反应和性腺类固醇水平。
主要发现
- 男性中来曲唑显著降低精氨酸刺激的GH峰值反应(均值±SEM;Δ-49.4%±18.1%,P<0.05)。
- 男性中他莫昔芬降低平均GH峰值,但未达统计学显著性。
- 绝经后女性中来曲唑不影响GH峰值。
- 绝经后女性中他莫昔芬显著降低GH峰值(Δ-47.3%±10%,P<0.05)。
- 男性中来曲唑降低循环雌二醇(从43.1±2.8至12.7±1.3 pmol/L;P<0.001);女性基线及来曲唑治疗期间雌二醇均检测不到(<11 pmol/L)。
临床怎么用
- 男性中使用芳香化酶抑制剂需关注对GH分泌的潜在抑制。
- 绝经后女性中他莫昔芬抑制GH分泌的机制可能非雌激素受体介导。
- 绝经后女性雌激素缺乏状态下芳香化酶抑制对GH影响有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Estrogen receptor antagonism by tamoxifen inhibits GH secretion in both men and postmenopausal women, suggesting that estrogen, albeit at low concentration, stimulates GH secretion. However, systemic estrogen replacement in postmenopausal women does not enhance GH secretion. To clarify the role of estrogen in mediating GH secretion, we investigated the effect of estrogen deprivation by using aromatase inhibitors. AIM: To determine whether estrogens mediate GH secretion in men and postmenopausal women. DESIGN: The effects of letrozole, an aromatase inhibitor, and tamoxifen were compared in an open-label crossover study. Eight men and 14 women received tamoxifen (20 mg/d) and letrozole (2.5 mg/d) for 2 weeks each. The primary endpoints were GH response to arginine stimulation and gonadal steroid levels. RESULTS: In men, letrozole significantly (P < 0.05) reduced the peak GH response to arginine (mean ± SEM; Δ -49.4% ± 18.1%). Tamoxifen also reduced the mean peak GH, but this did not reach statistical significance. In postmenopausal women, letrozole did not affect peak GH, whereas tamoxifen significantly (P < 0.05) reduced peak GH (Δ -47.3% ± 10%). In men, letrozole reduced circulating estradiol (from 43.1 ± 2.8 to 12.7 ± 1.3 pmol/L; P < 0.001), whereas in women estradiol was undetectable (<11 pmol/L) at baseline and throughout letrozole therapy. CONCLUSION: Because estrogen deprivation reduced circulating GH, we conclude that estrogens regulate GH secretion in men. In postmenopausal women, the neutral effect of aromatase inhibition is likely explained by pre-existing estrogen deficiency. The inhibition of GH secretion by tamoxifen in menopause suggests a non-estrogen receptor-mediated mechanism of action. In contrast to men, estrogen is unlikely to mediate GH secretion in postmenopausal women.
引用
- Birzniece V, McLean M, Reddy N, et al. Disparate Effect of Aromatization on the Central Regulation of GH Secretion by Estrogens in Men and Postmenopausal Women. J Clin Endocrinol Metab. 2019. PMID: 30920620. doi:10.1210/jc.2019-00265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。